Search

Boston, Mass. — The loss of tiny cells in the inner ear, known as “hair cells,” is a leading cause of hearing loss, a public health problem affecting at least one out of three people over the age of 65. Of the two varieties of hair cells, the “outer hair cells” act as micromotors that amplify...

We are pleased to introduce the five medical students who’ve been matched to our residency program this year. We look forward to their arrival and hope all will join us in welcoming them this June. Ciersten BurksMedical School: Indiana University Harvard otolaryngology resident Christopher...

First-year Harvard Ophthalmology resident Wendy Liu, MD, PhD, received the 2018 Gragoudas-Folkman Award, which will provide up to $20,000 to help fund her research on mechanosensitive ion channels in primary open-angle glaucoma. She will complete the project under the guidance of her mentor Janey...

The Department of Ophthalmology was, once again, well represented at this year’s Association for Research and Vision in Ophthalmology (ARVO) Imaging in the Eye Conference and Annual Meeting, held April 28 through May 3 in Honolulu, Hawaii. More than 145 faculty and trainees participated as course...

Last week, Harvard Medical School Professor of Otolaryngology and Director of the Thyroid and Parathyroid Surgery Division at Massachusetts Eye and Ear Dr. Gregory Randolph, alongside Dr. Peter Angelos of the University of Chicago and Dr. Whitney Liddy of Northwestern University, hosted the fourth...

Boston, Mass. — Patricia A. D’Amore, Ph.D., MBA, the Charles L. Schepens Professor of Ophthalmology at Harvard Medical School, Vice Chair for Basic and Translational Research, and Director of the Schepens Eye Research Institute of Massachusetts Eye and Ear has been elected to the American Academy of...

Chair of Harvard Ophthalmology will receive the 2018 Charles L. Schepens, MD/AAO Award and the Gertrude D. Pyron Award at upcoming meetings Joan W. Miller, MD, the David Glendenning Cogan Professor and Chair of Ophthalmology at Harvard Medical School and the Chief of Ophthalmology at Massachusetts...

SBIR funding by the NHLBI to Selexys results in the development of crizanlizumab. Selexys was founded in 2002 by Rodger (Rod) McEver, M.D., Richard Cummings, Ph.D., and Rick Alvarez, M.B.A. Read more here.

New technology enables identification of biomarkers for a wide range of diseases. Read more here.